Literature DB >> 19221475

Ubiquitination and deubiquitination of PCNA in response to stalling of the replication fork.

Stephanie Brown1, Atsuko Niimi, Alan R Lehmann.   

Abstract

Following exposure of human cells to DNA damaging agents that block the progress of the replication fork, mono-ubiquitination of PCNA mediates the switch from replicative DNA polymerases to polymerases specialised for translesion synthesis. We have shown that this modification of PCNA is necessary for the survival of cells after UV-irradiation and methyl methanesulfonate, that it is independent of cell cycle checkpoint activation, and that it persists after UV damage has been removed. In this Extra-view, we compare the regulation and biological significance of PCNA ubiquitination following treatments with UV light and the replication inhibitor hydroxyurea. We show that ubiquitination persists after removal of the replication block in both cases. With UV however, the persistence of ubiquitinated PCNA correlates with disappearance of the PCNA deubiquitinating enzyme USP1, whereas this is not the case for HU. Prevention of PCNA ubiquitination sensitises the cells to killing by both UV and HU.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221475     DOI: 10.4161/cc.8.5.7707

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  27 in total

Review 1.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 2.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

3.  PCNA-mediated stabilization of E3 ligase RFWD3 at the replication fork is essential for DNA replication.

Authors:  Yo-Chuen Lin; Yating Wang; Rosaline Hsu; Sumanprava Giri; Susan Wopat; Mariam K Arif; Arindam Chakraborty; Kannanganattu V Prasanth; Supriya G Prasanth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

4.  The effect of desalivation on the malignant transformation of the tongue epithelium and associated stromal myofibroblasts in a rat 4-nitroquinoline 1-oxide-induced carcinogenesis model.

Authors:  Marilena Vered; Osnat Grinstein-Koren; Shoshana Reiter; Irit Allon; Dan Dayan
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

5.  PIDD orchestrates translesion DNA synthesis in response to UV irradiation.

Authors:  E Logette; S Schuepbach-Mallepell; M J Eckert; X H Leo; B Jaccard; C Manzl; A Tardivel; A Villunger; M Quadroni; O Gaide; J Tschopp
Journal:  Cell Death Differ       Date:  2011-03-18       Impact factor: 15.828

6.  Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.

Authors:  J Kevin Hicks; Colleen L Chute; Michelle T Paulsen; Ryan L Ragland; Niall G Howlett; Quentin Guéranger; Thomas W Glover; Christine E Canman
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

7.  A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.

Authors:  X Chen; L Bosques; P Sung; G M Kupfer
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 8.  Dynamic regulation of PCNA ubiquitylation/deubiquitylation.

Authors:  Jennifer T Fox; Kyoo-young Lee; Kyungjae Myung
Journal:  FEBS Lett       Date:  2011-06-01       Impact factor: 4.124

9.  Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen.

Authors:  Mark Hedglin; Mahesh Aitha; Anthony Pedley; Stephen J Benkovic
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

Review 10.  REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.

Authors:  Shilpy Sharma; Christine E Canman
Journal:  Environ Mol Mutagen       Date:  2012-10-13       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.